Physician profile
Ashish K Jain
NPI 1841281003
$4,607.09
in general payments reported to CMS, 2019-2025
31 companies · $2,144 in 2025
The $2,144 reported for 2025 was more than what 84% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $173 · 2021: $574 · 2022: $365 · 2023: $573 · 2024: $603 · 2025: $2,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,485 · Travel and Lodging: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,485.12 |
| Travel and Lodging | $834.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,277.07 | 2025 | |
| Abbvie INC. | $890.58 | 2023-2025 | |
| Allergan, INC. | $656.15 | 2019-2022 | |
| Mentor Worldwide LLC | $519.46 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $180.04 | 2019-2025 | Integra, Omnigraft, Surgimend |
| Tela Bio, INC. | $162.03 | 2020-2024 | Ovitex 2s |
| Heron Therapeutics, INC. | $145.71 | 2024-2025 | Zynrelef |
| Sientra, INC. | $90.27 | 2022 | |
| Merz North America, INC. | $88.71 | 2021 | |
| Smith+Nephew, INC. | $70.26 | 2019-2024 | Grafix |
| Vertex Pharmaceuticals Incorporated | $63.38 | 2024-2025 | |
| Solventum Corporation | $61.07 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Otsuka America Pharmaceutical, INC. | $42.41 | 2021 | |
| Becton, Dickinson and Company | $37.69 | 2025 | Arista |
| Sanara Medtech INC. | $27.90 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $25.70 | 2025 | |
| W. L. Gore & Associates, INC. | $22.94 | 2019 | |
| Coopersurgical, INC. | $20.94 | 2020 | |
| Innovation Technologies INC | $20.64 | 2024 | Irrisept |
| Hydrofera LLC | $20.08 | 2025 | Hydrofera Blue |
| Lifenet Health | $18.94 | 2025 | Theragenesis Wound Matrix |
| Avanos Medical | $18.77 | 2021 | |
| Acera Surgical, INC. | $18.53 | 2024 | Restrata Wound Matrix |
| Kerecis Limited | $18.23 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Galderma Laboratories, L.P. | $17.82 | 2023 | Dysport |
| Lilly USA, LLC | $17.45 | 2025 | Zepbound |
| Ethicon US, LLC | $16.69 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $16.50 | 2022 | |
| Trevena, INC. | $15.65 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.98 | 2023 | Seglentis |
| Apyx Medical Corporation | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.